ALTUZAN Trademark

Trademark Overview

On Tuesday, January 27, 2004, a trademark application was filed for ALTUZAN with the United States Patent and Trademark Office. The USPTO has given the ALTUZAN trademark a serial number of 78358074. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, July 3, 2008. This trademark is owned by Genentech, Inc.. The ALTUZAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders
altuzan

General Information

Serial Number78358074
Word MarkALTUZAN
Filing DateTuesday, January 27, 2004
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, July 3, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2004

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, July 3, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990

Trademark Events

Event DateEvent Description
Thursday, July 3, 2008ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Thursday, July 3, 2008ABANDONMENT - AFTER PUBLICATION
Wednesday, July 2, 2008TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, January 10, 2008EXTENSION 5 GRANTED
Thursday, January 10, 2008EXTENSION 5 FILED
Thursday, January 10, 2008TEAS EXTENSION RECEIVED
Friday, June 29, 2007EXTENSION 4 GRANTED
Friday, June 29, 2007EXTENSION 4 FILED
Friday, June 29, 2007TEAS EXTENSION RECEIVED
Wednesday, December 20, 2006EXTENSION 3 GRANTED
Wednesday, December 20, 2006EXTENSION 3 FILED
Wednesday, December 20, 2006TEAS EXTENSION RECEIVED
Tuesday, September 19, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2006EXTENSION 2 GRANTED
Monday, June 19, 2006EXTENSION 2 FILED
Monday, June 19, 2006TEAS EXTENSION RECEIVED
Wednesday, December 14, 2005EXTENSION 1 GRANTED
Wednesday, December 14, 2005EXTENSION 1 FILED
Wednesday, December 14, 2005TEAS EXTENSION RECEIVED
Tuesday, July 12, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 13, 2005OPPOSITION TERMINATED NO. 999999
Friday, May 13, 2005OPPOSITION DISMISSED NO. 999999
Friday, February 18, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 25, 2004OPPOSITION INSTITUTED NO. 999999
Thursday, July 15, 2004EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, July 5, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 15, 2004PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2004NOTICE OF PUBLICATION
Tuesday, March 30, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 30, 2004ASSIGNED TO EXAMINER
Thursday, February 5, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

altuzan diseases disorders angiogenesis ocular inflammatory immune oncological cardiovascular preparations pharmaceutical